The UK National Institute for Health and Care Excellence (Nice) has unveiled a refreshed support service for the life sciences industry.
Known as NICE Advice, the service will offer precise scientific and strategic guidance, education and National Health Service (NHS) insights for pharmaceutical and healthtech businesses.
This approach will support the success of companies so that more patients can obtain access to top therapies and care.
NICE Advice will deliver scientific guidance and health system engagement discussions identical to those offered by the former support services, NICE Scientific Advice and the Office for Market Access.
The revamped service is easily accessible through an updated website and will aid healthtech businesses in utilising customised support based on development pace and budget allocations.
Precise guidance direct from NICE will assist businesses in ensuring the availability of the right evidence and approach to meet the standards required for product entry into the market.
NICE Advice will provide three kinds of customisable support: advice, insight and education.
Detecting gaps in data, offering technical scientific guidance on clinical and economic evidence strategies and conducting quality checks on economic models will be carried out with Nice Advice's support.
Insight support will offer valuable knowledge, such as a session with NICE experts and health system engagement discussions with specialists.
Education support will comprise webinars on NICE’s operations, health technology evaluation and evidence-based healthcare.
NICE medical technology and digital evaluation interim director Mark Chapman stated: “NICE Advice provides a single point of contact for individuals and organisations across the life sciences sector.
“By engaging with NICE Advice, organisations can benefit from our unrivalled expertise in health technology assessment, depth of knowledge, honest feedback and broad NHS connections.”
